Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
18.2M
-
Shares change
-
+53.5K
-
Total reported value, excl. options
-
$154M
-
Value change
-
+$826K
-
Number of buys
-
26
-
Number of sells
-
-30
-
Price
-
$8.46
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q4 2019
75 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q4 2019.
Apyx Medical Corp - Common Stock (APYX) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.2M shares
of 35M outstanding shares and own 52.17% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.39M shares), Archon Capital Management LLC (2.69M shares), BlackRock Inc. (2.23M shares), VANGUARD GROUP INC (1.45M shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (626K shares), RENAISSANCE TECHNOLOGIES LLC (623K shares), STATE STREET CORP (616K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), PURA VIDA INVESTMENTS, LLC (574K shares), and ROYCE & ASSOCIATES LP (512K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.